A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00821249 · COMPLETED
Trial details
- NCT number
- NCT00821249
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2016-03-16
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.